00:07:45.760If there's too much sugar to store as glycogen, the liver converts it into triglycerides,
00:07:50.080packages it into apolipoproteins, and ships them out.
00:07:54.200So what I want people to appreciate, though, is the scale of this.
00:07:57.840So everybody, you know, think about, you go to the doctor, you get a blood draw, and it's,
00:08:01.960you know, it's a fasting blood draw, right? And you get back a number. And so let's say that
00:08:07.340number you get back says 90 milligrams per deciliter. That was your blood glucose that
00:08:12.280morning when you showed up at the lab. If that's the case, your entire bloodstream in that moment
00:08:18.420contained only about four and a half grams of glucose. That's roughly a teaspoon, not a tablespoon,
00:08:25.400just a teaspoon. Yet a single meal, especially if it's a meal that I'm eating, may contain many
00:08:32.300times that, easily 90 grams of glucose, right? So 20 times that amount in one meal. And yet despite
00:08:41.180that, a healthy person rarely moves more than a teaspoon above baseline, right? In fact, I'm trying
00:08:49.940to think of all the times I wore a continuous glucose monitor, if I ever saw a blood glucose
00:08:55.780lever that would have been north of about 160 milligrams per deciliter. Someone with type 2
00:09:02.860diabetes would rarely go above a teaspoon and a half at fasting. And when we can go hours without
00:09:12.840eating, our glucose still stays in that range. In fact, if you go days without eating, it might
00:09:18.860only dip to, say, 50 milligrams per deciliter. This is a monumental homeostatic achievement.
00:09:26.840And that reserve capacity to titrate out glucose in such fine amounts is exactly why early
00:09:34.920dysfunction is very easy to miss, which is something we'll, I'm sure, talk about.
00:09:40.300Yeah. And so let's dive into more metabolic disease and how that affects the liver. And so
00:09:45.440when looking at that, is there a framework that you typically use, typically talk through with
00:09:50.280patients in explaining it? Yeah. I think the most useful framing is to consider metabolic liver
00:09:57.780disease moving through four stages. So in the first stage, the liver becomes metabolically
00:10:04.200stressed. And then the second stage in response to that, it starts storing excess, excess energy
00:10:11.400that is as fat. And that's a condition known as steatosis. And then the third stage is
00:10:18.200steatohepatitis. And that is just a fancy word for excess fat being stored in the liver, tips
00:10:24.580the liver into inflammation, and then the liver begins to injure itself. And then the fourth
00:10:31.080stage is the response to that injury, where it starts to lay down scar tissue. And that's a term
00:10:38.200that people have probably heard called fibrosis in the liver. So those first three stages are
00:10:44.820largely reversible. It's fibrosis that is a little trickier. It is biologically reversible to varying
00:10:53.020degrees, especially if caught on the very, very early side of things. But once the scarring
00:10:59.600accumulates into such that the liver's architecture is disrupted, that's the point that becomes
00:11:07.060irreversible. Now, the presence of fibrosis is what predicts the outcomes that we typically care
00:11:13.440about, especially cardiovascular disease, cancer, and even liver-specific mortality. So as we kind
00:11:19.060of go through this exercise, I'll keep pointing back to where we are on that four-part scheme.
00:11:25.420And you previously said that, you know, chronic calorie surplus is a primary driver of metabolic
00:11:32.280dysfunction. And so can you walk us through the chain of the events from caloric surplus to
00:11:38.700ultimately at the end, liver damage? Yeah, it starts relatively simply. If you consume more
00:11:45.180calories than you expend consistently, the body has to put that excess energy somewhere. And the
00:11:51.740liver converts much of it into triglycerides through a process of de novo lipogenesis.
00:11:57.680It packages them into these ApoB-containing particles, namely VLDLs and LDLs, and ships them to adipose tissue for long-term storage. And again, that is a normal, healthy, physiologic response. If we didn't have that capacity, we wouldn't be here today. You and I wouldn't be talking together. Our species would have gone extinct because we had to be able to store energy when energy was abundant, and we had to be able to draw from that when energy was scarce.
00:12:28.620It's obviously, as you can see, it's going to become abnormal at some point.
00:12:32.080So think of a fat cell as a warehouse.
00:12:34.440For a while, they will accept every shipment.
00:12:37.260But as they become progressively overfilled, they stop responding normally to insulin,
00:12:44.060which is kind of the most important hormone that's involved in this process.
00:12:47.220And one of the molecular hallmarks of that process is the accumulation of a lipid intermediate called diacylglycerol, or DAG, or DAG, which interrupts insulin signaling.
00:13:00.840So once that happens, the warehouse starts malfunctioning.
00:13:04.980Instead of simply storing fat, those particular fat cells or adipocytes begin releasing fatty acids back into the bloodstream.
00:13:13.280exactly what you don't want unless you're about to use them immediately. The problem is there's
00:13:19.200already too much energy in circulation. So the last place you want more triglycerides is being
00:13:24.100released back into the bloodstream. So now the liver has to deal not only with the excess calories
00:13:28.820coming in from the diet, but also the excess fat coming back into the circulation from those
00:13:34.300defective fat cells. And what happens to the free fatty acids in the blood?
00:13:39.900So the liver picks up those fatty acids, as well as the fats from our diet, because that's one of the primary jobs is energy balance. But eventually the same process develops here. So lipid intermediates begin to accumulate, insulin signaling becomes impaired, and the liver becomes insulin resistant.
00:14:03.440Now, people may recall back to the podcast that we did with Ralph DeFranco on this, and it's one of my favorite podcasts of the past year or two because it's just a master class in all of the different types of insulin resistance.
00:14:18.880And insulin resistance in the muscle versus the fat cell versus the pancreas versus the liver, they all look a little bit different.
00:14:23.900I'm not going to get into that now, but if anybody wants to sort of get really brushed up on that, that's where we'll go, and we'll link to that in the podcast.
00:14:31.020But here's the part that's really important.
00:14:32.940Insulin normally tells the liver to do two things.
00:14:36.960Stop releasing glucose into the bloodstream
00:29:40.480And from liver-specific disease, death is up 1,400%.
00:29:47.420So again, the purpose of me sharing this
00:29:51.260is not to tell you never to have another drink.
00:29:53.460it's to explain that when you add alcohol to liver disease, it gets really bad. Now, if we look at the
00:30:00.520pattern of drinking, there might be some, again, something to glean here. So, acetyl aldehyde is
00:30:08.160the primary driver of alcohol's harm on the liver, and it accumulates faster the more you exceed
00:30:16.720about one drink per hour. Therefore, mechanistically, I get asked this question all the time,
00:30:23.640but I think what we could say is seven drinks in one evening is probably worse for you than
00:30:32.720one drink per night, seven consecutive nights. Again, I haven't seen the data for that, but
00:30:40.040when you understand the mechanism of action, I think that makes sense. But that's basically,
00:30:43.820I think the point here is that, you know, human data directly comparing binge versus daily
00:30:49.980drinking don't exist for the metabolic disease. And I suspect we're not going to have an RCT for
00:30:55.020that, but that's kind of the point on alcohol and metabolic liver disease.
00:30:59.980And to follow up on the NHANES study, do we know how much alcohol they were actually drinking?
00:31:07.600Yeah. Again, everything is self-reported. So it's possible that this is what they were drinking.
00:31:12.280It's also possible this is a slight underestimate. I believe the men were drinking something to the tune of 40 to 60 grams a day, and the women would have needed to be a bit less than that. We'll put the exact numbers in the show notes page, but that means that these are people that are self-reporting three, at least three drinks a day, maybe four drinks a day.
00:31:32.580because again 60 grams of ethanol is technically for normal sized drinks or potentially less if
00:31:40.340you're drinking you know if you're pouring it yourself the point i would also add to that nick
00:31:45.200is there are lots of people who can drink that amount and they're totally functional so i don't
00:31:49.200want the interpretation to be this is only for people you know who are rampant alcoholics because
00:31:56.680Lots of people can be drinking three drinks a day and obviously have no obvious side effects of that.
00:32:04.340And so moving beyond just lifestyle factors, so when looking at the liver, are there any people who are at greater risk at the baseline, whether that's from genetics, hormones, or something else?
00:32:18.140Yep. I would put these into two buckets, the inherited genetic piece and then obviously the hormonal piece, which can fluctuate over time.
00:32:24.500So on the inherited side, the most important single gene variant here is something called PNPLA3.
00:32:32.500And people who carry two copies of a particular variant here tend to have about 2x the risk of, or the likelihood of accumulating liver fat.
00:32:43.340And then with that comes the elevated risk of inflammation and fibrosis, even after accounting for standard metabolic risk factors.
00:32:50.380There are also variants that appear protective, especially a loss of function variant in a gene
00:32:58.100called HSD17b13, which is associated with lower liver enzymes and fibrosis risk. And it may
00:33:05.740actually partially offset the PNPLA3 associated risk. There are other variants as well. Again,
00:33:11.880we'll kind of list them in the show notes for completeness. But I think the larger point here
00:33:16.060is that there is an absolute genetic predisposition and even some protection that we see. And it,
00:33:24.400I mean, I think any clinician can attest to this, right? You've got that patient who,
00:33:29.180for whatever reason, two people doing the exact same things and they have completely different
00:33:33.900liver health. It's also why ancestry can show up in population level risk, though, you know,
00:33:39.700we have to be careful not to overstate it. So the PNPLA3 risk variant is much more common in people
00:33:45.740with Hispanic ancestry. So that's why at the population level, we know that Hispanics are0.99
00:33:50.340much more sensitive to, and therefore susceptible to Masldi and MASH. And it's actually the exact0.97
00:33:58.040opposite in people of African ancestry. So that likely contributes to what we see clinically.
00:34:05.480But again, that doesn't mean at the individual level, that's always the case. So I don't want
00:34:09.540someone who's listening to this, who's black to think, great, I can't get Masldi, you know,1.00
00:34:14.420away I go. And I don't want someone who's Hispanic to listen to this and say, oh, well,1.00
00:34:18.240great. This is my destiny. It's just, again, it's a predisposition, but it's, it's, you know,
00:34:22.980it's not destiny. So, I mean, there are also now body composition differences that standard labs
00:34:28.680and BMI stuff can always miss. So for example, many people who are of Asian ancestry develop
00:34:34.920metabolic risk at lower and normal BMIs in part, again, because visceral adiposity can be higher
00:34:41.120at a given body weight in a group of people who otherwise don't genetically accumulate much
00:34:46.660subcutaneous fat. So again, this is why I think body weight and BMI, while at the population
00:34:52.340level are useful tools, at the individual level offer nothing. I wouldn't be able to tell you
00:34:57.200the BMI of one of my patients, but I can tell you virtually every one of their total body fat,
00:35:02.260visceral fat, and other measurements that are more nuanced. So that's what really matters.
00:35:06.460The other major baseline modifier is menopause. So premenopausal women are relatively protected. The net effect of estrogen here appears to be restraining visceral and hepatic fat accumulation. Of course, after menopause, that protection starts to fade and it can do so quite quickly. And then fatty liver becomes more common and can progress actually more aggressively.0.99
00:35:31.900So again, all of these things, ancestry, family history, genotype, menopause status, all of these things belong in the risk assessment. But again, none of them replaces the core question, which is what is the person's actual metabolic phenotype? So I don't want to get too hung up on knowing what increases or decreases risk beyond what I just said. I think what we really want to focus on is how do you actually measure it objectively in yourself unambiguously.
00:35:58.600Peter, let's move into that, which is how people figure out kind of their liver health in a way.
00:36:04.500So I think if you ask most people, they would assume that if they go get annual blood work done
00:36:08.880and their liver enzymes come back normal, everything is fine with their liver. So first
00:36:13.480and foremost, would you say that is true? Thank you for listening to today's sneak peek
00:36:18.520AMA episode of The Drive. If you're interested in hearing the complete version of this AMA,
00:36:23.760you'll want to become a premium member. It's extremely important to me to provide all of this
00:36:28.660content without relying on paid ads. To do this, our work is made entirely possible by our members,
00:36:34.320and in return, we offer exclusive member-only content and benefits above and beyond what is
00:36:40.100available for free. So if you want to take your knowledge of this space to the next level, it's
00:36:44.340our goal to ensure members get back much more than the price of the subscription. Premium membership
00:36:49.560includes several benefits. First, comprehensive podcast show notes that detail every topic,
00:36:56.300paper, person, and thing that we discuss in each episode. And the word on the street is
00:37:00.820nobody's show notes rival ours. Second, monthly Ask Me Anything or AMA episodes.
00:37:07.660These episodes are comprised of detailed responses to subscriber questions typically
00:37:11.940focused on a single topic and are designed to offer a great deal of clarity and detail
00:37:17.080on topics of special interest to our members. You'll also get access to the show notes for
00:37:21.500these episodes, of course. Third, delivery of our premium newsletter, which is put together
00:37:26.940by our dedicated team of research analysts. This newsletter covers a wide range of topics
00:37:32.240related to longevity and provides much more detail than our free weekly newsletter.
00:37:37.760Fourth, access to our private podcast feed that provides you with access to every episode,
00:37:43.200including AMA's sans the spiel you're listening to now, and in your regular podcast feed.
00:37:49.620Fifth, The Qualies, an additional member-only podcast we put together that serves as a highlight
00:37:55.540reel featuring the best excerpts from previous episodes of The Drive. This is a great way to
00:38:00.680catch up on previous episodes without having to go back and listen to each one of them.
00:38:05.020And finally, other benefits that are added along the way. If you want to learn more and access
00:38:10.120these member-only benefits, you can head over to peteratiamd.com forward slash subscribe.
00:38:16.320You can also find me on YouTube, Instagram, and Twitter, all with the handle peteratiamd.
00:38:21.800You can also leave us a review on Apple Podcasts or whatever podcast player you use. This podcast
00:38:28.120is for general informational purposes only and does not constitute the practice of medicine,
00:38:32.620nursing, or other professional healthcare services, including the giving of medical advice.
00:38:37.840No doctor-patient relationship is formed.
00:38:40.120The use of this information and the materials linked to this podcast is at the user's own risk.
00:38:46.400The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
00:38:52.620Users should not disregard or delay in obtaining medical advice from any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions.
00:39:02.360Finally, I take all conflicts of interest very seriously. For all of my disclosures and the
00:39:07.960companies I invest in or advise, please visit peteratiamd.com forward slash about where I keep
00:39:15.220an up-to-date and active list of all disclosures.